XML 21 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Income Statement [Abstract]    
Revenues $ 17,836,382 $ 4,620,834
Cost of goods sold 14,155,836 5,455,145
Gross profit (loss) 3,680,546 (834,311)
Operating Expenses    
Research and development 5,896,037 5,595,281
Sales and marketing 4,568,617 3,731,776
General and administrative 10,679,105 12,383,470
Impairment loss 412,999 2,826,918
Total operating expenses 21,556,758 24,537,445
Operating loss (17,876,212) (25,371,756)
Other (income) expense    
Gain on divestiture of consumer segment (9,642,427)
Impairment on equity method investment 11,353,875
Equity method loss 503,625
Investment loss (income), net 651,943 (82,798)
Interest expense 68,609 122,004
Other, net 714,859 965,681
Other (income) expense 3,650,484 1,004,887
Net loss from continuing operations (21,526,696) (26,376,643)
Loss from discontinued operations (2,525,933) (1,730,386)
Net loss $ (24,052,629) $ (28,107,029)
Loss per share - basic and diluted    
Continuing operations $ (0.36) $ (0.49)
Discontinued operations (0.04) (0.03)
Loss per share - basic and diluted $ (0.40) $ (0.52)
Weighted average shares outstanding - basic and diluted 60,118,675 53,860,199